Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3969 results

Sort By:

The Efficacy and Safety of Puerarin in Obesity Treatment

Study ID: NCT06968208
Start Date: 2025-08-01
End Date: 2029-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

80

Intervention / Treatment

Puerarin

Placebo

Sponsor

Ruisin Hospital

Source: clinicaltrials.gov

Share:
Add to list

Phase I/II Clinical Trial of Proteasome Inhibitor in Combination With CPX-351 for the Treatment of Newly-Diagnosed TP53-mutated Acute Myeloid Leukemia (AML)

Study ID: NCT07008638
Start Date: 2025-07-01
End Date: 2028-01-27
Study Type

Interventional

Study Phase

Phase2

No. of Participants

32

Intervention / Treatment

Bortezomib

CPX-351

Sponsor

Masonic Cancer Center, University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Study ID: NCT06859008
Start Date: 2026-02-07
End Date: 2028-01-28
Study Type

Interventional

Study Phase

Phase1

No. of Participants

37

Intervention / Treatment

Biopsy

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Computed Tomography

Magnetic Resonance Imaging

Administration questionnaire

Sonrotoclax

Zanubrutinib

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Ultrasound and Somatosensory Median Nerve Evaluation in CRPS I

Study ID: NCT06978608
Start Date: 2025-09-01
End Date: 2026-02-26
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment
Sponsor

Careggi Hospital-University

Source: clinicaltrials.gov

Share:
Add to list

ENA-001 for Post Operative Respiratory Depression (PORD)

Study ID: NCT06137638
Start Date: 2026-03-15
End Date: 2026-12-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

200

Intervention / Treatment

This-001

Sponsor

Enalare Therapeutics Inc.

Source: clinicaltrials.gov

Share:
Add to list

Geriatric Assessment and Technology Evaluation in Prostate Cancer

Study ID: NCT06215508
Start Date: 2026-04
End Date: 2031-04
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

Questionnaires

Sponsor

University of Chicago

Source: clinicaltrials.gov

Share:
Add to list

Study of Zatolmilast (BPN14770) in Participants With PPP2R5D Neurodevelopmental Disorder (Jordan's Syndrome [JS])

Study ID: NCT06717438
Start Date: 2027-03-01
End Date: 2030-01-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

BPN14770

Placebo

Sponsor

Shionogi

Source: clinicaltrials.gov

Share:
Add to list

Strategies to Decentralize Breast Ultrasound in Rwanda

Study ID: NCT06812208
Start Date: 2026-04-01
End Date: 2029-11-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1792

Intervention / Treatment

Teleultrasound with Philips Lumify ultrasound probes and Reacts software

Asynchronous virtual feedback

Sponsor

Brigham and Women's Hospital

Source: clinicaltrials.gov

Share:
Add to list

Parents' HPV Stories

Study ID: NCT06704308
Start Date: 2025-11
End Date: 2026-11
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

58

Intervention / Treatment

Web Application

Provider Elaborated Prompts

Sponsor

Anne E Ray

Source: clinicaltrials.gov

Share:
Add to list

Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma

Study ID: NCT06708455
Start Date: 2025-11-15
End Date: 2028-09-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

65

Intervention / Treatment

RAPA-201 Rapamycin Resistant T Cells

Chemotherapy Prior to RAPA-201 Therapy

Sponsor

Rapa Therapeutics LLC

Source: clinicaltrials.gov

Share:
Add to list